Antimitotic Agents: all 5,052 studies that test it

Page 40 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.

• Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell CancerActive, not recruitingNCT00494182Phase 2
• A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With CancerStatus unknownNCT00491946Phase 4
• Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal CarcinomatosisCompletedNCT00491855Phase 1
• Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian CancerCompletedNCT00490711Phase 2
• H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell HistiocytosisWithdrawnNCT00488605Phase 3
• Treatment of Larotaxel/Docetaxel, +/- Trastuzumab, After Anthracycline-cyclophosphamide in Breast Cancer PatientsCompletedNCT00485979Phase 2
• Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerCompletedNCT00483782Phase 3
• A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic MelanomaCompletedNCT00483301Phase 2
• Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate CancerCompletedNCT00482807Phase 1
• Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast CancerCompletedNCT00480597Phase 2
• A Phase II Trial of TPI 287 in Patients With Metastatic Prostate CancerTerminatedNCT00479635Phase 2
• ABI-008 Trial in Patients With Hormone-refractory Prostate CancerCompletedNCT00477529Phase 1/2
• A Phase I Study of Intraperitoneal Hyperthermic DocetaxelCompletedNCT00474669Phase 1
• Phase I Study of the Combination of Satraplatin and Abraxane in Advanced CancersCompletedNCT00473720Phase 1
• Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast CancerCompletedNCT00472693Phase 2
• OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid TumorsCompletedNCT00471432Phase 1
• Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877TerminatedNCT00471367Phase 1
• A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer.WithdrawnNCT00471159Phase 2
• The Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced MalignanciesTerminatedNCT00468260Phase 1
• Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast CancerCompletedNCT00467012Phase 2
• Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian CancerCompletedNCT00466986Phase 2
• Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung CancerTerminatedNCT00465907Phase 2
• Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute LeukemiaCompletedNCT00462787Phase 1
• Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical CancerStatus unknownNCT00462397Phase 2
• Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast CancerTerminatedNCT00461344Phase 2
• Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic MalignanciesTerminatedNCT00460460Phase 1
• PR-104 and Docetaxel or Gemcitabine in Treating Patients With Solid TumorsCompletedNCT00459836Phase 1
• Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary TumorWithdrawnNCT00458315Phase 2
• CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's LymphomaTerminatedNCT00455897Phase 2
• Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer PatientsTerminatedNCT00453635Phase 2
• Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal CancerStatus unknownNCT00453323Phase 2
• Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung CancerCompletedNCT00453167Phase 2
• Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical CancerWithdrawnNCT00452920Phase 1/2
• The ELDORADO (Eligard®, Docetaxel and Radiotherapy) StudyStatus unknownNCT00452556Phase 2
• Phase I/II Study of Neoadjuvant Lapatinib in Breast CancerCompletedNCT00450892Phase 1/2
• Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast CancerWithdrawnNCT00450515Phase 2
• Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate CancerTerminatedNCT00450008Phase 2
• Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLCTerminatedNCT00449657Phase 2
• Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung CancerCompletedNCT00449020Phase 2
• Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced MalignanciesCompletedNCT00448396Phase 1
• EndoTAG-1 in Triple Receptor Negative Breast Cancer PatientsCompletedNCT00448305Phase 2
• Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before ProstatectomyTerminatedNCT00448097Phase 2
• Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by SurgeryCompletedNCT00445861Phase 1/2
• Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension)WithdrawnNCT00442741Phase 1
• Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLCTerminatedNCT00442026Phase 3
• Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)CompletedNCT00441922Phase 3
• Study of EC0225 for the Treatment of Refractory or Metastatic TumorsCompletedNCT00441870Phase 1
• Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Cell Lung CancerCompletedNCT00441740Phase 3
• The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With CancerCompletedNCT00440128Phase 1
• Taxotere Prostate Cancer New Indication Registration Trial in ChinaCompletedNCT00436839Phase 3
• Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast CancerStatus unknownNCT00436709Not applicable
• Taxotere + Cisplatin in Nasopharyngeal CarcinomaCompletedNCT00436293Phase 2
• Alimta and Gemcitabine in Non-Small Cell Lung CancerCompletedNCT00434135Phase 2
• CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast CancerWithdrawnNCT00434031Phase 2
• Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph NodesCompletedNCT00433589Phase 3
• Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast CancerActive, not recruitingNCT00433420Phase 3
• Docetaxel in Non Small Cell Lung Cancer (NSCLC)CompletedNCT00432315Phase 2
• Investigation of Mass Balance of the Test Drug and Major MetabolitesCompletedNCT00432302Phase 1
• VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast CancerStatus unknownNCT00431704Phase 2
• Vinorelbine and Gemcitabine Versus Capecitabine in Pretreated Metastatic Breast CancerCompletedNCT00431106Phase 3
• Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast CancerCompletedNCT00431080Phase 3
• Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian CancerCompletedNCT00431054Phase 1
• Vinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast CancerStatus unknownNCT00430001Phase 3
• Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's LymphomaCompletedNCT00428142Phase 2
• Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By SurgeryCompletedNCT00427570Phase 3
• Combination Trial of Patupilone and Carboplatin in Adult Patients With Advanced Solid TumorsCompletedNCT00426582Phase 1
• Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies.CompletedNCT00426140Phase 1
• Breast Cancer Treated by Neoadjuvant ChemotherapyCompletedNCT00425516Phase 2
• Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer PatientsCompletedNCT00424606Phase 3
• Epothilone ZK-219477 in Treating Patients With Recurrent GlioblastomaCompletedNCT00424060Phase 2
• A Safety Study of EPC2407, A Anti-Cancer Drug With Vascular Disrupting Activity: In Patients With Advanced CancerCompletedNCT00423410Phase 1
• Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary TractTerminatedNCT00422877Phase 2
• A Study Evaluating BSI-201 in Combination With Chemotherapeutic Regimens in Subjects With Advanced Solid TumorsCompletedNCT00422682Phase 1
• A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic FunctionCompletedNCT00421044Phase 1
• Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced MalignanciesCompletedNCT00420615Phase 1
• A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic FunctionCompletedNCT00420524Phase 1
• Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing RegimenCompletedNCT00417209Phase 3
• Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00416533Phase 2
• ZANTE: Zometa and Taxotere in Hormone Refractory Prostate CancerCompletedNCT00415779Phase 1
• Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00415324Phase 1
• Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast CancerStatus unknownNCT00415285Phase 2
• Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00415116Phase 1
• Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in JapanCompletedNCT00412789Phase 1
• Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic LeukemiaCompletedNCT00411541Phase 4
• Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate CancerCompletedNCT00411528Phase 2
• Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial CancerActive, not recruitingNCT00411138Phase 3
• Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by SurgeryCompletedNCT00410553Phase 1
• Abraxane and Temodar Plus Genasense in Advanced MelanomaStatus unknownNCT00409383Phase 1
• Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00408655Phase 1
• Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung CancerCompletedNCT00408226Phase 1/2
• ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CarcinomaTerminatedNCT00407407Phase 1
• Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel ChemotherapyCompletedNCT00407251Phase 2
• Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)CompletedNCT00406302Phase 2
• Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)in Combination With Docetaxel for the Treatment of Non-Small Cell Lung CancerCompletedNCT00405951Phase 1/2
• Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck CancerCompletedNCT00405405Phase 1
• Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic CancerCompletedNCT00405210Phase 1
• Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast CarcinomaTerminatedNCT00403988Phase 2
• C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT00402545Phase 1
• A Study of CNTO 328 in Patients With Metastatic Hormone-Refractory Prostate CancerCompletedNCT00401765Phase 1
• MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian CancerCompletedNCT00401674Phase 2

← Antimitotic Agents overview